“We downgrade our rating to ‘fully valued’ on a lower target price of $0.41 from $0.80,” says lead analyst Rachel Tan.
SINGAPORE (Aug 11): DBS is staying positive on Singapore O&G’s medium-term growth potential but the research house is cautious on the near-term potential headwinds.
This follows lower earnings recorded in 1H17 and potential increase in cost from the gestation period in ramping-up paediatrics division.
